Loading...
Market
What will be the revenue growth of Johnson & Johnson's MedTech cardiovascular portfolio by December 31, 2025?
2
Resolution / Starting Odds
Less than 5% • 25%
5% to 10% • 25%
10% to 15% • 25%
More than 15% • 25%
Johnson & Johnson's annual financial report
Story
Johnson & Johnson to Acquire V-Wave for Up to $1.7 Billion
Aug 20, 2024, 11:53 AM
Johnson & Johnson has announced its agreement to acquire V-Wave, a privately-held company specializing in innovative treatment options for heart failure. The acquisition involves an upfront payment of $600 million, with the total deal potentially reaching up to $1.1 billion, contingent on achieving specific milestones. Some reports suggest the deal could be worth up to $1.7 billion. This strategic move aims to enhance Johnson & Johnson's MedTech cardiovascular portfolio, particularly through V-Wave's innovative Ventura® technology.
View original story
Similar markets
Below $7.5 billion • 25%
$7.5 billion to $8 billion • 25%
$8 billion to $8.5 billion • 25%
Above $8.5 billion • 25%
5.7% to 6.2% • 25%
Less than 5.7% • 25%
More than 6.2% • 25%
Other • 25%
Below $21 billion • 25%
$21 billion to $22 billion • 25%
$22 billion to $23 billion • 25%
Above $23 billion • 25%
Less than $10 billion • 25%
$10 billion to $15 billion • 25%
$15 billion to $20 billion • 25%
More than $20 billion • 25%
Yes • 50%
No • 50%
Below $5 billion • 25%
$5 billion to $5.5 billion • 25%
$5.5 billion to $6 billion • 25%
Above $6 billion • 25%
BridgeBio Pharma • 25%
Pfizer • 25%
Other • 25%
Tie • 25%
Less than $10M • 25%
$10M to $50M • 25%
$50M to $100M • 25%
More than $100M • 25%
Less than $500 million • 25%
$500 million - $1 billion • 25%
$1 billion - $1.5 billion • 25%
More than $1.5 billion • 25%